Physician profile
James M Patton
NPI 1518945690
$136,146.07
in general payments reported to CMS, 2019-2025
95 companies · $2,534 in 2025
The $2,534 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $33K · 2021: $18K · 2022: $7,797 · 2023: $3,142 · 2024: $2,770 · 2025: $2,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,418 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $825 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,418.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $825.00 |
| Education | $203.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $29,658.28 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Allergan, INC. | $28,185.87 | 2019-2022 | |
| Emd Serono, INC. | $23,827.37 | 2019-2023 | Mavenclad |
| Acorda Therapeutics, INC | $17,790.89 | 2019-2024 | Inbrija, Ampyra |
| Kyowa Kirin, INC. | $9,684.92 | 2019-2022 | |
| Abbvie INC. | $7,142.92 | 2019-2025 | |
| Genzyme Corporation | $6,796.26 | 2019-2025 | |
| Mdd US Operations, LLC | $954.56 | 2019-2025 | Gocovri, Apokyn, Apokyn |
| Teva Pharmaceuticals USA, INC. | $827.44 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $681.86 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $672.16 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $515.84 | 2019-2025 | Ultomiris |
| Amgen INC. | $504.12 | 2019-2025 | Uplizna, Aimovig |
| Jazz Pharmaceuticals INC. | $412.26 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $395.82 | 2019-2025 | Nuplazid |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $385.86 | 2019-2025 | Ingrezza, Ongentys |
| Supernus Pharmaceuticals, INC. | $371.55 | 2019-2022 | |
| Eisai INC. | $370.00 | 2019-2025 | |
| Sk Life Science, INC. | $286.78 | 2020-2025 | |
| Catalyst Pharmaceuticals, INC. | $286.52 | 2021-2025 | Firdapse, Fycompa |
| Amneal Pharmaceuticals LLC | $270.85 | 2019-2025 | Crexont, Rytary, Brekiya |
| Lilly USA, LLC | $266.10 | 2019-2025 | Reyvow, Emgality, Kisunla |
| Pfizer INC. | $265.24 | 2019-2025 | |
| Neurelis, INC. | $261.33 | 2021-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $215.00 | 2019-2022 | |
| Celgene Corporation | $197.86 | 2021-2025 | Zeposia |
| Avanir Pharmaceuticals, INC. | $197.04 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $196.56 | 2021-2025 | Xeomin, Inbrija |
| Greenwich Biosciences, INC. | $195.95 | 2019-2021 | |
| Averitas Pharma INC. | $189.58 | 2023-2025 | Qutenza |
| Lundbeck LLC | $183.56 | 2019-2023 | Vyepti, Rexulti |
| Csl Behring | $182.75 | 2019-2023 | Hizentra |
| Argenx US, INC. | $167.07 | 2022-2025 | Vyvgart Hytrulo |
| Ipsen Biopharmaceuticals, INC | $156.87 | 2021-2025 | Dysport |
| Tg Therapeutics, INC. | $155.77 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $153.45 | 2021-2024 | Amvuttra |
| Janssen Pharmaceuticals, INC | $149.89 | 2021-2023 | Ponvory |
| E.R. Squibb & Sons, L.L.C. | $138.20 | 2020-2024 | Zeposia |
| Genentech USA, INC. | $138.11 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Tanabe Pharma America, INC. | $132.19 | 2021-2025 | Radicava |
| Abbott Laboratories | $117.75 | 2019-2025 | Infinity |
| Mallinckrodt Hospital Products INC. | $108.88 | 2022-2025 | Acthar |
| Horizon Therapeutics Plc | $104.56 | 2022-2023 | Uplizna |
| Sumitomo Pharma America, INC. | $101.76 | 2023-2024 | Aptiom |
| Revance Therapeutics, INC. | $95.67 | 2024-2025 | Daxxify |
| Upsher-Smith Laboratories LLC | $90.07 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $89.44 | 2022-2024 | Ztlido |
| Otsuka America Pharmaceutical, INC. | $86.63 | 2023-2025 | Rexulti, Nuedexta |
| Mallinckrodt Enterprises LLC | $85.68 | 2019 | |
| Xeris Pharmaceuticals, INC. | $85.67 | 2021-2025 | Keveyis |
| Grifols USA, LLC | $77.01 | 2019-2022 | |
| Adamas Pharmaceuticals, INC. | $75.52 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $75.27 | 2022-2024 | Purified Cortrophin Gel |
| Biohaven Pharmaceuticals, INC. | $73.57 | 2021 | |
| Insightec,INC | $72.92 | 2023-2025 | Exablate |
| Cycle Pharmaceuticals INC | $67.49 | 2025 | Tascenso Odt, Ormalvi, Bafiertam |
| Vanda Pharmaceuticals INC. | $61.86 | 2025 | Ponvory |
| Medtronic USA, INC. | $59.91 | 2020 | |
| Aquestive Therapeutics, INC. | $56.46 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $55.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.17 | 2019-2025 | Hyqvia |
| Astrazeneca Pharmaceuticals LP | $51.06 | 2024-2025 | Wainua |
| Axsome Therapeutics, INC. | $50.45 | 2023-2025 | Sunosi, Symbravo |
| Banner Life Sciences, LLC | $46.99 | 2022 | |
| Impel Pharmaceuticals LLC | $45.62 | 2025 | Trudhesa |
| Cala Health, INC. | $42.58 | 2022-2023 | Cala Trio |
| Piramal Critical Care | $41.51 | 2019 | |
| Grt US Holding, INC. | $40.67 | 2022 | |
| Boston Scientific Corporation | $37.43 | 2019-2022 | |
| Nevro Corp. | $36.57 | 2024 | Senza |
| Merz North America, INC. | $36.44 | 2019 | |
| Merck Sharp & Dohme LLC | $33.07 | 2020-2021 | |
| C2n Diagnostics, LLC | $27.78 | 2025 | Precivityad2 |
| Medtronic, INC. | $27.41 | 2024-2025 | Percept PC Brainsense, Intellis Adaptivestim |
| Assertio Therapeutics, INC. | $26.10 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $23.43 | 2024 | Dojolvi |
| Ge Healthcare | $23.19 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $23.07 | 2025 | Lumryz |
| Octapharma USA, INC. | $22.79 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $22.13 | 2022 | |
| Corium, LLC | $21.85 | 2023 | Adlarity |
| Avion Pharmaceuticals | $21.67 | 2022 | |
| Janssen Biotech, INC. | $21.18 | 2025 | |
| Sandoz INC. | $20.61 | 2024 | |
| Mylan Specialty L.P. | $19.14 | 2023 | Glatiramer Acetate |
| Neuropace, INC. | $18.80 | 2023 | |
| Hospira, INC. | $18.15 | 2022 | |
| Bausch Health US, LLC | $16.79 | 2019 | |
| Akcea Therapeutics, INC. | $16.51 | 2021 | |
| Conmed Corporation | $16.37 | 2025 | Visiclear |
| Promius Pharma LLC | $12.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.47 | 2021 | |
| Strongbridge US INC. | $12.42 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Botox $932Gocovri $738Qulipta $449Ubrelvy $403Austedo Xr $274Ultomiris $238Nurtec Odt $198Fintepla $193Epidiolex $193Qutenza $190Valtoco $187Ingrezza $187Zavzpret $173Zeposia $164Nuplazid $163Briumvi $156Vumerity $146Firdapse $145Leqembi $144Vyvgart Hytrulo $144Tysabri $134Uplizna $128Skyclarys $124Dysport $120Xeomin $115Fycompa $114Aptiom $102Daxxify $95.67Rexulti $86.80Acthar $85.43Briviact $80.76Kesimpta $79.51Radicava $78.02Ponvory $77.51Amvuttra $73.89Exablate $72.92Ztlido $71.63Apokyn $70.65Nayzilam $69.39Inbrija $65.63Aimovig $65.44Mayzent $58.90Keveyis $57.90Duopa $56.72Vyepti $55.23Hizentra $52.72Wainua $51.06Reyvow $49.33Emgality $49.33Radicava Ors $47.07Xadago $46.83Trudhesa $45.62Mavenclad $43.66Tascenso Odt $43.30Kisunla $42.32Crexont $42.28Purified Cortrophin Gel $41.11Rytary $40.57Spinraza $39.80Amyvid $39.50Infinity $38.16Senza $36.57Zilbrysq $32.33Ampyra $29.69Ongentys $28.62Precivityad2 $27.78Enspryng $26.47Ocrevus $26.47Sunosi $25.88Hyqvia $25.68Paxlovid $24.60Comirnaty $24.60Symbravo $24.57Qalsody $24.37Ormalvi $24.19Bafiertam $24.06Dojolvi $23.43Lumryz $23.07Adlarity $21.85Brekiya $21.74Nuedexta $20.87Nexviazyme $20.73Vraylar $20.28Octagam Immune Globulin (Human) $19.20Panzyga $19.20Glatiramer Acetate $19.14Rns Neurostimulator Kit $18.80Zembrace Symtouch $18.65Tosymra $18.65Cala Trio $16.59Visiclear $16.37Ocrevus Zunovo $16.13Tecfidera $15.81Austedo $14.76Percept PC Brainsense $14.26Intellis Adaptivestim $13.15
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.